Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma

Oral Oncol. 2022 Jul:130:105922. doi: 10.1016/j.oraloncology.2022.105922. Epub 2022 May 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / genetics
  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Head and Neck Neoplasms* / genetics
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Mutation
  • Squamous Cell Carcinoma of Head and Neck
  • Tumor Suppressor Protein p53 / genetics

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53